Extended adjuvant hormonal therapy with exemestane has no detrimental effect on the lipid profile of postmenopausal breast cancer patients: final results of the ATENA lipid substudy.

Breast Cancer Res · 2009 · PMC2716503 · PMID 19531217

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an overall trendno p-value reported

Our final findings from the ATENA lipid substudy confirm the protective effect of tamoxifen on the lipid profile and indicate an overall trend for increasing cholesterol levels after cessation of tamoxifen in the whole population.

also in 3,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.